Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line
- 8 April 2003
- journal article
- Published by Elsevier in Protein Expression and Purification
- Vol. 29 (1) , 58-69
- https://doi.org/10.1016/s1046-5928(03)00011-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences 2. Immunogenicity in poor responders to hepatitis B vaccinesVaccine, 1997
- Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigensVaccine, 1991
- Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)Vaccine, 1991
- Immune response to hepatitis B revaccinationJournal of Medical Virology, 1988
- A candidate vaccine for hepatitis B containing the complete viral surface proteinHepatology, 1988
- Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region.Proceedings of the National Academy of Sciences, 1985
- Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin.Proceedings of the National Academy of Sciences, 1984
- CLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINEThe Lancet, 1984
- Human hepatitis B vaccine from recombinant yeastNature, 1984
- A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final reportHepatology, 1981